Relation of HLA-DRB1 to IgG4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)
Göster/ Aç
Erişim
info:eu-repo/semantics/embargoedAccessTarih
2019Yazar
Çebi, MerveDurmuş, Hacer
Yılmaz, Vuslat
Yentür, Sibel Penbe
Aysal, Fikret
Oflazer, Zehra Piraye
Parman, Yeşim Gülşen
Deymeer, Feza
Saruhan-Direskeneli, Güher
Üst veri
Tüm öğe kaydını gösterKünye
Çebi, M., Durmuş, H., Yılmaz, V., Yentür S. P., Aysal, F., Oflazer, Z. P. ve Saruhan Direskeneli, G. (2019). Relation of HLA-DRB1 to IgG4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG). Clinical and Experimental Immunology, 197(2), 214-221. https://dx.doi.org/10.1111/cei.13302Özet
A small subset of myasthenia gravis (MG) patients develop autoantibodies against muscle-specific kinase (MuSK), which are predominantly of the immunoglobulin (Ig)G4 isotype. MuSK-MG is strongly associated with HLA-DRB1*14, HLA-DRB1*16 and HLA-DQB1*05. In this study, the possible effects of these HLA associations on MuSK IgG autoantibody or cytokine production were investigated. Samples from 80 MG patients with MuSK antibodies were studied. The disease-associated HLA types were screened in the DNA samples. The IgG1, IgG2, IgG3 and IgG4 titres of the MuSK antibodies and the levels of interleukin (IL)-4, IL-6, IL-17A and IL-10 were measured in the sera. Comparisons were made among the groups with or without HLA-DRB1*14, HLA-DRB1*16 or HLA-DQB1*05. The IgG4 titres of the MuSK antibodies were higher than those of the IgG1, IgG2 and IgG3 isotypes among the whole group of patients. DRB1*14 (+) DRB1*16 (–) patients had higher levels of IgG4 antibodies than those of DRB1*14 (–) DRB1*16 (+) patients. DRB1*14 (+) DRB1*16 (+) patients also had higher levels of IgG4 antibodies than those of DRB1*14 (–) DRB1*16 (+) and DRB1*14 (–) DRB1*16 (–) patients. Higher IL-10 and lower IL-17A levels were measured in DRB1*14 (+) DRB1*16 (–) patients than in DRB1*14 (–) DRB1*16 (–) patients. The higher IgG4 titres of MuSK autoantibodies in patients carrying HLA-DRB1*14 than those in the other patients suggest a role for HLA in the production of the antibodies. The differences in IL-10 and IL-17A support the role of DRB1 in the etiopathogenesis of this autoimmune response.
WoS Q Kategorisi
Q2Scopus Q Kategorisi
Q2Kaynak
Clinical and Experimental ImmunologyCilt
197Sayı
2Koleksiyonlar
- Makale Koleksiyonu [3650]
- PubMed İndeksli Yayınlar Koleksiyonu [4048]
- Scopus İndeksli Yayınlar Koleksiyonu [6284]
- WoS İndeksli Yayınlar Koleksiyonu [6432]